SUSE S.A. financials
SUSE S.A.
Country: LU Reporting currency: USD Latest annual report: 2022-10-31
LEI:
213800C9JTKV8DLW6403 Financial statements
(USD, as reported — unscaled; 118 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | $653.0M | $559.5M |
| Cost of sales | $51.9M | $43.2M |
| Gross profit | $601.2M | $516.3M |
| Administrative expenses | $153.1M | $310.2M |
| Depreciation & amortisation | $142.0M | $142.0M |
| Operating profit (EBIT) | -$499.0K | -$200.9M |
| Net finance income / (cost) | -$40.7M | -$58.9M |
| Finance costs | $40.7M | $58.9M |
| Profit before tax | -$43.5M | -$261.9M |
| Income tax expense | -$4.0M | -$54.3M |
| Profit for the year | -$39.5M | -$207.6M |
| — attributable to owners | -$39.5M | -$207.6M |
| — attributable to NCI | $0 | $0 |
| Total comprehensive income | $16.8M | -$200.3M |
| Per share | ||
| Basic EPS | $-0.20 | $-2.50 |
| Diluted EPS | $-0.20 | $-2.50 |
| Free cash flow / share | $0.69 | $-0.02 |
| Cash flow statement | ||
| Cash generated from operations | $194.3M | $58.4M |
| Net cash from operating activities | $147.2M | $2.8M |
| Net cash from investing activities | -$16.9M | -$602.1M |
| Purchase of PP&E (capex) | $10.6M | $4.8M |
| Purchase of intangibles | $3.2M | $10.5M |
| Net cash from financing activities | -$15.8M | $564.9M |
| Proceeds from borrowings | $0 | $310.0M |
| Repayments of borrowings | $3.6M | $524.0M |
| Lease liability payments | $7.8M | $4.5M |
| Net change in cash | $114.5M | -$34.3M |
| Balance sheet | ||
| Total assets | $3.77B | $3.74B |
| Non-current assets | $3.39B | $3.51B |
| Property, plant & equipment | $13.9M | $8.2M |
| Right-of-use assets | $18.1M | $14.4M |
| Intangible assets & goodwill | $2.69B | $2.69B |
| Current assets | $377.0M | $229.6M |
| Trade & other receivables | $158.0M | $138.0M |
| Cash & equivalents | $177.5M | $61.1M |
| Total equity | $2.25B | $2.19B |
| Non-current liabilities | $1.04B | $1.07B |
| Long-term borrowings | $696.0M | $742.1M |
| Lease liabilities (non-current) | $14.4M | $10.7M |
| Current liabilities | $482.0M | $485.3M |
| Short-term borrowings | $3.6M | $3.6M |
| Lease liabilities (current) | $6.2M | $6.0M |
| Trade & other payables | $110.5M | $129.7M |
| Deferred tax liabilities | $98.8M | $107.1M |
| Derived metrics | ||
| Free cash flow | $136.5M | -$2.0M |
| Operating margin | -0.1% | -35.9% |
| Net margin | -6.0% | -37.1% |
| Return on equity | -1.8% | -9.5% |
| Cash conversion ratio | -3.73× | -0.01× |
| Capex coverage | 13.83× | 0.59× |
| Other reported items | ||
| Adjustments For Decrease Increase In Contract Assets | -$46.3M | -$46.1M |
| Adjustments For Decrease Increase In Other Operating Receivables | -$747.0K | -$594.0K |
| Adjustments For Decrease Increase In Trade Account Receivable | -$19.9M | -$20.6M |
| Adjustments For Finance Income Cost | -$40.7M | -$58.9M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | -$171.0K | -$265.0K |
| Adjustments For Increase Decrease In Contract Liabilities | $53.3M | $63.4M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -$351.0K | $562.0K |
| Adjustments For Increase Decrease In Other Operating Payables | -$32.7M | $12.4M |
| Adjustments For Increase Decrease In Trade Account Payable | $4.1M | $4.8M |
| Adjustments For Provisions | -$4.5M | -$8.0M |
| Adjustments For Sharebased Payments | $52.2M | $175.2M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -$2.3M | -$2.1M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $17.2M | $12.6M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $2.5M | $586.8M |
| Cash Repayments of Advances and Loans From Related Parties | $0 | -$1.5M |
| Comprehensive Income Attributable To Noncontrolling Interests | $0 | $0 |
| Comprehensive Income Attributable To Owners of Parent | $16.8M | -$200.3M |
| Current Contract Assets | $37.8M | $28.9M |
| Current Deferred Income Including Current Contract Liabilities | $351.2M | $329.6M |
| Current Provisions | $337.0K | $4.9M |
| Current Tax Assets | $3.6M | $1.7M |
| Current Tax Liabilities Current | $10.1M | $11.5M |
| Current Tax Liabilities Noncurrent | $8.1M | $7.4M |
| Deferred Tax Assets | $178.7M | $190.0M |
| Depreciation Expense | $3.7M | $4.5M |
| Depreciation Rightofuse Assets | $7.3M | $6.5M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $2.0M | $432.0K |
| Equity and Liabilities | $3.77B | $3.74B |
| Finance Income | $9.0K | $8.0K |
| Gains Losses On Cash Flow Hedges Before Tax | $4.0M | -$502.0K |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade Receivables | -$171.0K | -$265.0K |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | $3.0M | $2.1M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | $1.4M | -$1.0K |
| Income Taxes Paid Refund Classified As Operating Activities | $15.5M | $8.0M |
| Increase Decrease Through Conversion of Convertible Instruments | $0 | — |
| Increase Decrease Through Sharebased Payment Transactions | $51.3M | $18.0M |
| Increase Decrease Through Transactions With Owners | $46.9M | $938.9M |
| Intangible Assets Other Than Goodwill | $393.4M | $537.1M |
| Interest Paid Classified As Financing Activities | $4.4M | $9.0M |
| Interest Paid Classified As Operating Activities | $31.7M | $47.6M |
| Interest Received Classified As Operating Activities | $9.0K | $8.0K |
| Investments In Associates | $12.3M | $14.0M |
| Issued Capital | $16.9M | $16.9M |
| Liabilities | $1.52B | $1.56B |
| Noncurrent Contract Assets | $78.2M | $55.5M |
| Noncurrent Deferred Income Including Noncurrent Contract Liabilities | $215.0M | $178.2M |
| Noncurrent Derivative Financial Assets | $4.1M | $6.0K |
| Noncurrent Derivative Financial Liabilities | $0 | $5.2M |
| Noncurrent Provisions | $1.0M | $1.0M |
| Noncurrent Receivables | $8.7M | $7.9M |
| Noncurrent Recognised Assets Defined Benefit Plan | $484.0K | $648.0K |
| Noncurrent Recognised Liabilities Defined Benefit Plan | $2.1M | $6.6M |
| Other Comprehensive Income | $56.3M | $7.4M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | $48.4M | $1.6M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | $3.9M | -$590.0K |
| Other Noncurrent Payables | $3.9M | $13.6M |
| Other Reserves | $72.5M | $21.2M |
| Payments For Debt Issue Costs | $0 | $3.8M |
| Proceeds From Issuing Shares | $0 | $659.4M |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | -$4.4M | -$9.0M |
| Research and Development Expense | $113.2M | $100.1M |
| Reserve of Cash Flow Hedges | $4.1M | -$4.3M |
| Reserve of Exchange Differences On Translation | $33.5M | -$14.9M |
| Retained Earnings | -$400.3M | -$355.9M |
| Sale Or Issue of Treasury Shares | — | $669.5M |
| Share Issue Related Cost | $4.4M | $14.7M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | -$2.3M | -$2.1M |
| Share Premium | $2.52B | $2.52B |
Methodology
Every line item above is a fact tagged in SUSE S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.